{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:58:16Z","timestamp":1784757496654,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.idnow.2024.104955","type":"journal-article","created":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T21:38:39Z","timestamp":1721597919000},"page":"104955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Voriconazole as an alternative oral treatment in fluconazole-resistant urinary candidiasis"],"prefix":"10.1016","volume":"54","author":[{"given":"Christelle","family":"Boglione-Kerrien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Le Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Luque Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6595-8154","authenticated-orcid":false,"given":"Marie-Cl\u00e9mence","family":"Verdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Guegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bellissant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.idnow.2024.104955_b0005","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00345-019-02991-5","article-title":"Candida urinary tract infections in adults","volume":"38","author":"Odabasi","year":"2020","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.idnow.2024.104955_b0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.purol.2011.02.004","article-title":"Recommendations of the Infectious Disease Committee of the French Association of Urology. Diagnosis, treatment and monitoring candiduria","volume":"21","author":"Fraisse","year":"2011","journal-title":"Prog Urol"},{"key":"10.1016\/j.idnow.2024.104955_b0015","series-title":"The Sanford guide to antimicrobial therapy 2021","author":"Gilbert","year":"2021"},{"issue":"3","key":"10.1016\/j.idnow.2024.104955_b0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/03602532.2019.1632888","article-title":"Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism","volume":"51","author":"Schulz","year":"2019","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.idnow.2024.104955_b0025","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idnow.2024.104955_b0030","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1515\/CCLM.2010.252","article-title":"Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma","volume":"48","author":"Verdier","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.idnow.2024.104955_b0035","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on Bioanalytical Method Validation. 2011; European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf (accessed 17 April 2024)."},{"issue":"12","key":"10.1016\/j.idnow.2024.104955_b0040","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cmi.2019.04.027","article-title":"Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex","volume":"25","author":"Sals\u00e9","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idnow.2024.104955_b0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idnow.2024.104955_b0050","first-page":"1","article-title":"High prevalence of asymptomatic nosocomial candiduria due to Candida glabrata among hospitalized patients with heart failure: a matter of some concern?","volume":"6","author":"Aghili","year":"2020","journal-title":"Curr Med Mycol"},{"issue":"5","key":"10.1016\/j.idnow.2024.104955_b0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/13693786.2011.618996","article-title":"Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria","volume":"50","author":"Ozhak-Baysan","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.idnow.2024.104955_b0060","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1590\/s1678-9946201759075","article-title":"Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil","volume":"59","author":"Lima","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"5","key":"10.1016\/j.idnow.2024.104955_b0065","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1086\/510432","article-title":"Caspofungin in the treatment of symptomatic candiduria","volume":"44","author":"Sobel","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idnow.2024.104955_b0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0897190016645032","article-title":"Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients","volume":"30","author":"Sullivan","year":"2017","journal-title":"J Pharm Pract"},{"issue":"Suppl 6","key":"10.1016\/j.idnow.2024.104955_b0075","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1093\/cid\/cir112","article-title":"Candida urinary tract infections\u2013treatment","volume":"52","author":"Fisher","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idnow.2024.104955_b0080","doi-asserted-by":"crossref","first-page":"e01651","DOI":"10.1128\/AAC.01651-19","article-title":"Mechanisms of Acquired In Vivo and In Vitro Resistance to Voriconazole by Candida krusei following Exposure to Suboptimal Drug Concentration","volume":"64","author":"Ricardo","year":"2020","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:53:21Z","timestamp":1725090801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991924001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666991924001222"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104955","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voriconazole as an alternative oral treatment in fluconazole-resistant urinary candidiasis","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104955"}}